Could scorpion venom inspire new treatments for liver disease?
From blocking inflammatory immune pathways to disrupting hepatitis viruses, scorpion-derived peptides are attracting attention as potential drug candidates,…
Lancet review examines possible amyloid-beta transmission through blood transfusions
A review and opinion piece published in The Lancet and led by UCL (University College London) and UCLH…
Microbial metabolites could help improve functional cure rates for hepatitis B
Chronic hepatitis B (CHB) remains a major global challenge. Current therapies suppress HBV but rarely achieve functional cure…
Scientists discover why mouse liver cells resist hepatitis E virus
Mouse liver cells are not a suitable host for hepatitis E viruses. The Virology department in Bochum has…
Occult hepatitis B mutations drive liver cancer growth via Akt mTOR pathway
Occult hepatitis B virus (OBI) infection presents a significant global health challenge, notoriously flying under the radar of…
Integrating gene signatures and multi omics improves liver cancer treatment
Hepatocellular carcinoma (HCC) remains highly fatal due to late diagnosis and scarce early biomarkers. Multi‑omics and liquid biopsy…
New viral library helps scientists study thousands of proteins
To prevent viruses from sickening or killing us – whether it’s an individual case of hepatitis B or…
ABL Diagnostics Announces Renewal of U.S. Patent (US 8,859,198 B2) for Hepatitis B Genotyping and Antiviral Resistance
Reinforcing long-term IP strength in molecular diagnostics and supporting global laboratory partners WOIPPY, FRANCE, June 15, 2026 /EINPresswire.com/…
Chronic liver disease threatens millions across Europe, report finds
Europe is facing a growing chronic liver disease threat, according to a new Series published today in The…
Combination therapy improves response rates for chronic hepatitis B patients
Background and aims The optimal management strategy for adults with immune-tolerant (IT) chronic hepatitis B infection remains undefined.…
DNA-guided CRISPR system targets RNA and expands Cas12 beyond gene editing
A DNA-guided CRISPR platform could make RNA detection and control more stable, scalable, and precise, opening new routes…
Colbopasvir plus sofosbuvir achieves high cure rates in chronic hepatitis C
Abstract In this real‑world multicenter study (Wenzhou, China), 113 chronic hepatitis C patients received colbopasvir (60 mg) +…